Q4 2016 13F Holders as of 12/31/2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
82.8M
-
Number of holders
-
83
-
Total 13F shares, excl. options
-
23.5M
-
Shares change
-
+1.33M
-
Total reported value, excl. options
-
$381M
-
Value change
-
+$22.3M
-
Number of buys
-
39
-
Number of sells
-
-26
-
Price
-
$16.23
Significant Holders of Editas Medicine, Inc. - Common Stock (EDIT) as of Q4 2016
93 filings reported holding EDIT - Editas Medicine, Inc. - Common Stock as of Q4 2016.
Editas Medicine, Inc. - Common Stock (EDIT) has 83 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23.5M shares
of 82.8M outstanding shares and own 28.38% of the company stock.
Largest 10 shareholders include FMR LLC (5.5M shares), Polaris Venture Management Co. VI, L.L.C. (3.8M shares), Flagship Pioneering Inc. (3.46M shares), Viking Global Investors LP (1.71M shares), DEERFIELD MANAGEMENT CO (1.71M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.63M shares), VANGUARD GROUP INC (1.32M shares), BlackRock Fund Advisors (713K shares), EcoR1 Capital, LLC (627K shares), and Capital World Investors (295K shares).
This table shows the top 83 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.